Who Is Eligible for Mounjaro on the NHS — and What Most People Get Wrong

The myth: a high BMI is all the NHS needs to see

Plenty of people search for Mounjaro NHS eligibility expecting the answer to be a simple number on the BMI scale, and our Mounjaro NHS eligibility guide explains why the reality is more layered. NICE's appraisal of tirzepatide (TA1026, published in December 2024) recommends it for adults with a BMI of at least 35 plus at least one weight-related comorbidity. But NHS England's interim commissioning guidance went further, phasing access by cohort based on how many serious conditions a person has alongside their BMI.

That distinction matters. The medicine's licence is broader than the NHS access criteria. A prescriber working within NHS commissioning rules must apply the phased thresholds, not just the licence. So even if tirzepatide is clinically appropriate for you, you may not yet qualify through your GP surgery or specialist service.

One useful check you can do right now: look up your BMI using the NHS BMI calculator and count which of the five qualifying conditions you carry. That two-minute exercise will tell you which cohort, if any, you currently fall into.

What the phased rollout actually says, cohort by cohort

The five qualifying conditions NHS England references are: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. Against those, here is where the rollout stands.

The first cohort opened from June 2025: adults with a BMI of 40 or above, carrying four or more of those five conditions. Cohort 2 followed on 23 June 2026, extending access to people with a BMI between 35 and 39.9 who also have four or more conditions. From around March 2027, the threshold for conditions drops to three, still at a BMI of 40 or above.

Ethnic-background adjustments apply throughout: the qualifying BMI at each band is typically 2.5 kg/m² lower for South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds. Every NHS patient must also take part in structured wrap-around dietary and physical activity support, the medicine is prescribed alongside a supervised programme, not instead of one. Meeting the criteria on paper does not guarantee immediate access; availability varies by GP practice and integrated care board. More detail on how those thresholds sit together is set out on our Mounjaro NHS eligibility criteria page.

GP prescribing, waiting lists, and the private alternative

From 1 April 2026, GP practices in England can prescribe tirzepatide directly under the updated GP contract (QOF 2026/27). Participation is optional, though, so your surgery may not be offering it yet. Specialist weight management services remain the other NHS route, and their waiting lists in many areas run to months or longer.

For people who are wondering who can get Mounjaro on the NHS, the current phased criteria apply, and those who don't meet them (or who do meet them but don't want to wait) can consider a private prescription as the alternative. Through a regulated online pharmacy, the assessment is based on the medicine's licensed eligibility rather than NHS commissioning rules: broadly, a BMI of 30 or above, or 27 with at least one weight-related condition. That private route is faster and doesn't require a referral, but it is still a prescription-only medicine. A qualified prescriber reviews every application; eligibility is never assumed.

The cost context is worth understanding too. The Eli Lilly price increase that took effect in September 2025 pushed private prices significantly higher across the board, our Mounjaro price increase explainer covers what changed and what it means for private patients. Whether that's relevant to you depends on which route you're pursuing.

If you're unsure which route fits your situation, our page covering whether you are eligible for Mounjaro on the NHS pulls the key facts together. Our clinical team also reviews every private consultation personally, a real prescriber, not an automated triage tool.

If you don't qualify for NHS Mounjaro right now

Not qualifying today doesn't mean not qualifying ever. The cohort criteria are due to widen further, and individual clinical circumstances can change. It's worth keeping a record of your diagnoses and asking your GP to note any relevant conditions on your Summary Care Record, that paperwork matters when cohort thresholds shift.

In the meantime, the private licensed route is available for adults who meet the licence criteria, subject to prescriber assessment, and our guidance on who can buy Mounjaro sets out exactly what those criteria involve. Tirzepatide dispensed privately is the same medicine, from the same licensed UK supply chain, as the NHS version. The clinical oversight differs in structure but not in principle: every prescription still requires a qualified prescriber to sign it off. A broader look at what treatment options currently exist sits on our weight-loss treatments overview.

Questions about the process, the medicine, or whether private assessment makes sense for your situation: our team is available seven days a week. There's no obligation in asking.